down arrow

Concord Biotech

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE338H01029
  • NSEID: CONCORDBIO
  • BSEID: 543960
INR
1,660.00
59.35 (3.71%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 68.17 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1,609.201,675.55

52 Week

1,326.902,658.00
Valuation
Technical
Day's Volume

CASH

68.17 k (30.95%) Volume

Shareholding (Dec 2024)

FII

8.33%

Held by 90 FIIs

DII

9.66%

Held by 14 DIIs

Promoter

44.08%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Flat results in Dec 24

  • NET SALES(Q) At Rs 244.22 cr has Fallen at -10.0% (vs previous 4Q average)
  • PBT LESS OI(Q) At Rs 86.42 cr has Fallen at -14.1% (vs previous 4Q average)
  • PAT(Q) At Rs 75.92 cr has Fallen at -7.4% (vs previous 4Q average)
2

Stock is technically in a Bearish range

3

With ROE of 20.6, it has a Very Expensive valuation with a 10.5 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 17,366 Cr (Mid Cap)

stock-summary
P/E

51.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.55%

stock-summary
Debt Equity

-0.18

stock-summary
Return on Equity

20.62%

stock-summary
Price to Book

10.53

Revenue and Profits (1 Year):
Net Sales:
244 Cr
(Quarterly Results - Dec 2024)
Net Profit:
76 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.55%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-12.45%
0%
-12.45%
1 Year
10.21%
0.53%
10.74%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Latest dividend: 8.75 per share ex-dividend date: Jun-21-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
19.40%
EBIT Growth (5y)
30.13%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.64
Tax Ratio
25.80%
Dividend Payout Ratio
30.04%
Pledged Shares
0
Institutional Holding
17.99%
ROCE (avg)
27.41%
ROE (avg)
20.62%
Valuation key factors
Factor
Value
P/E Ratio
51
Industry P/E
33
Price to Book Value
10.53
EV to EBIT
41.50
EV to EBITDA
36.57
EV to Capital Employed
12.57
EV to Sales
15.12
PEG Ratio
NA
Dividend Yield
0.55%
ROCE (Latest)
30.87%
ROE (Latest)
20.62%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 20 Schemes (4.86%)

FIIs

Held by 90 FIIs (8.33%)

Promoter with highest holding

Sudhir Vaid (28.84%)

Highest Public shareholder

Aryavir Jhunjhunwala Discretionary Trust (8.03%)

Individual Investors Holdings

7.33%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -21.27% vs 43.73% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -20.70% vs 60.66% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "244.22",
          "val2": "310.18",
          "chgp": "-21.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "97.95",
          "val2": "136.67",
          "chgp": "-28.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "75.92",
          "val2": "95.74",
          "chgp": "-20.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "40.11%",
          "val2": "44.06%",
          "chgp": "-3.95%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 15.05% vs 34.50% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 14.63% vs 90.24% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "525.98",
          "val2": "457.17",
          "chgp": "15.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "217.95",
          "val2": "191.34",
          "chgp": "13.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.34",
          "val2": "1.59",
          "chgp": "-78.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "155.33",
          "val2": "135.51",
          "chgp": "14.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "41.44%",
          "val2": "41.85%",
          "chgp": "-0.41%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 10.35% vs 20.22% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 8.53% vs 43.39% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "770.20",
          "val2": "697.97",
          "chgp": "10.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "315.90",
          "val2": "297.28",
          "chgp": "6.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.44",
          "val2": "2.09",
          "chgp": "-78.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "231.25",
          "val2": "213.08",
          "chgp": "8.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "41.02%",
          "val2": "42.59%",
          "chgp": "-1.57%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 19.20% vs 19.67% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 28.33% vs 37.25% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,016.94",
          "val2": "853.17",
          "chgp": "19.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "431.56",
          "val2": "343.29",
          "chgp": "25.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.55",
          "val2": "4.51",
          "chgp": "-43.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "308.10",
          "val2": "240.09",
          "chgp": "28.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "42.44%",
          "val2": "40.24%",
          "chgp": "2.20%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
244.22
310.18
-21.27%
Operating Profit (PBDIT) excl Other Income
97.95
136.67
-28.33%
Interest
0.10
0.10
Exceptional Items
0.00
0.00
Consolidate Net Profit
75.92
95.74
-20.70%
Operating Profit Margin (Excl OI)
40.11%
44.06%
-3.95%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -21.27% vs 43.73% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -20.70% vs 60.66% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
525.98
457.17
15.05%
Operating Profit (PBDIT) excl Other Income
217.95
191.34
13.91%
Interest
0.34
1.59
-78.62%
Exceptional Items
0.00
0.00
Consolidate Net Profit
155.33
135.51
14.63%
Operating Profit Margin (Excl OI)
41.44%
41.85%
-0.41%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 15.05% vs 34.50% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 14.63% vs 90.24% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
770.20
697.97
10.35%
Operating Profit (PBDIT) excl Other Income
315.90
297.28
6.26%
Interest
0.44
2.09
-78.95%
Exceptional Items
0.00
0.00
Consolidate Net Profit
231.25
213.08
8.53%
Operating Profit Margin (Excl OI)
41.02%
42.59%
-1.57%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 10.35% vs 20.22% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 8.53% vs 43.39% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
1,016.94
853.17
19.20%
Operating Profit (PBDIT) excl Other Income
431.56
343.29
25.71%
Interest
2.55
4.51
-43.46%
Exceptional Items
0.00
0.00
Consolidate Net Profit
308.10
240.09
28.33%
Operating Profit Margin (Excl OI)
42.44%
40.24%
2.20%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 19.20% vs 19.67% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 28.33% vs 37.25% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Concord Biotech Ltd stock-summary
stock-summary
Concord Biotech Ltd
Mid Cap
Pharmaceuticals & Drugs
Concord Biotech Limited was originally incorporated as `Servomed Pharmaceuticals Private Limited' at Ahmedabad, Gujarat as a Private Limited Company dated November 23, 1984, issued by the Registrar of Companies. Thereafter, name of the Company was changed to `Concord Biotech Limited' dated February 16, 2001, which became a Public Company and a fresh Certificate of Incorporation dated November 7, 2001 was issued by the RoC.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."